Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


12 Nov 2016 - 16 Nov 2016
16 Nov 2016 - 19 Nov 2016

3-Photon Microscopy Breaks Depth Limit of Current Biological Tissue Imaging

By BiotechDaily International staff writers
Posted on 07 Feb 2013
Print article
Image:  A horizontal frame from 3D reconstructed 3-photon microscopy images in a mouse brain. Red: neurons, blue: blood vessels, dark holes: nonfluorescent neurons (Photo courtesy of Prof. Xu’s laboratory, Cornell University).
Image: A horizontal frame from 3D reconstructed 3-photon microscopy images in a mouse brain. Red: neurons, blue: blood vessels, dark holes: nonfluorescent neurons (Photo courtesy of Prof. Xu’s laboratory, Cornell University).
In a proof-of-concept study of a live mammalian brain, scientists have now shown that 3-photon microscopy enables high-resolution, noninvasive in vivo imaging at unprecedented depths of complex biological tissue, breaking the fundamental depth limit of standard 2-photon microscopy.

The team of scientists, at Cornell University (Ithaca, NY, USA), have demonstrated a three-fold improvement in the depth limit of fluorescence-based biological tissue imaging over the widely used 2-photon microscopy (2PM) based technology (invented at Cornell in 1990). Tissue scattering limits the maximum imaging depth of 2PM to the cortical layer of the mouse brain, and imaging subcortical structures currently requires the removal of overlying brain tissue or the insertion of optical probes. Senior investigator Chris Xu, associate professor of applied and engineering physics, and colleagues have now demonstrated high-resolution, 3D imaging of the subcortical region of a live, intact mouse brain using 3-photon microscopy (3PM) based imaging technology (invented at Cornell in 1995).

The study, published online January 20, 2013, in the journal Nature Photonics, describes 3-photon fluorescence combined with a longer excitation wavelength of the laser pulse to overcome obstacles such as tissue scattering and absorption, which have prohibited high-resolution imaging deep within biological tissues. Dyes and transgenic mice were used to test the 3PM on different fluorescent signals. Using the live mouse brain model, the researchers have proved the principle of 3PM operating at a wavelength of 1,700 nanometers and this, in combination with the new laser developed specifically for 3-photon excitation, allowed for the high-resolution imaging at unprecedented depths within the brain—vascular structures as well as neurons within the mouse hippocampus were imaged.

"With MRI, we can see the whole brain but not with the resolution we have demonstrated. The optical resolution is about 100 to 1,000 times higher and allows us to clearly visualize individual neurons," said Prof. Xu. Pushing these depth limits is important for basic science and could also prove useful clinically, Prof. Xu noted. Depression and diseases like Parkinson's and Alzheimer's are associated with changes deep inside the brain, and finding the cures could be helped by subcortical neural imaging—below the gray matter, into the white matter and beyond, if the brain is visualized as stacked layers. If 3-photon microscopy can be used to map the entire brain, it could pave the way to new breakthroughs in neuroscience as well as other clinically relevant areas.

Related Links:

Cornell University

Print article


Drug Discovery

view channel
Image: Positive alpha-synuclein staining of a Lewy body from a patient with Parkinson\'s disease (Photo courtesy of Wikimedia Commons).

Bifunctional Dimer Drugs Prove Effective in Parkinson's Disease Yeast Model

A team of Canadian neurodegenerative disease researchers used a yeast model system to identify novel drug compounds that were able to block the misfolding of alpha- synuclein (AS) protein, which characterizes... Read more


view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more


view channel

Collaborative Agreement to Aid in Setting Guidelines for Evaluating Potential Ebola Therapy

Cooperation between an Israeli biopharmaceutical company and medical branches of the US government is designed to set ground rules for continued evaluation of an experimental therapy for Ebola virus disease. RedHill Biopharma Ltd. (Tel Aviv, Israel), a biopharmaceutical company primarily focused on development and c... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.